Shayna Sarosiek, MD

Assistant Professor, Medicine

Shayna Sarosiek
820 Harrison Ave

Biography

Dr. Shayna Sarosiek, MD, MS is an Assistant Professor of Medicine in Hematology and Medical Oncology for the Boston University School of Medicine. Dr. Sarosiek completed her fellowship in Hematology & Oncology and Amyloidosis at Boston Medical Center, in which she was Chief Fellow in Hematology & Oncology. Dr. Sarosiek, also completed her residency and internship at Boston Medical Center. She received her MD from the University of Miami School of Medicine, her MS in Biomedicine from Barry University and her BA from Wake Forest University.

Education

  • University of Miami School of Medicine, MD

Classes Taught

  • GMS MM 707

Publications

  • Published on 6/19/2018

    Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V. Modified high-dose melphalan and autologous stem cell transplantation for AL amyloidosis: Experience in 334 patients. Biol Blood Marrow Transplant. 2018 Jun 19. PMID: 29933072.

    Read at: PubMed
  • Published on 6/14/2018

    Sarosiek S, Quillen K, Sloan JM, Brauneis D, Sanchorawala V. Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation. Blood. 2018 Jun 14. PMID: 29903887.

    Read at: PubMed
  • Published on 6/8/2018

    White PS, Phull P, Brauneis D, Sloan JM, Quillen K, Sarosiek S, Sanchorawala V. High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers. Bone Marrow Transplant. 2018 Jun 08. PMID: 29884854.

    Read at: PubMed
  • Published on 4/26/2018

    Pudusseri A, Smith I, Sarnacki D, Brauneis D, Shelton A, Sanchorawala V, Sloan JM, Sarosiek S, Quillen K. Evaluation of a new continuous mononuclear cell collection procedure in a single transplant center cohort enriched for AL amyloidosis patients. Transfus Apher Sci. 2018 Apr 26. PMID: 29731423.

    Read at: PubMed
  • Published on 3/8/2018

    Jhaveri T, Sarosiek S, Ruberg FL, Siddiqi O, Berk JL, Sanchorawala V. Once AL amyloidosis: not always AL amyloidosis. Amyloid. 2018 Mar 08; 1-2. PMID: 29516761.

    Read at: PubMed
  • Published on 2/9/2018

    Phull P, Sanchorawala V, Connors LH, Doros G, Ruberg FL, Berk JL, Sarosiek S. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR). Amyloid. 2018 Mar; 25(1):62-67. PMID: 29424556.

    Read at: PubMed
  • Published on 12/21/2017

    Nguyen VP, Brauneis D, Kaku M, Sloan JM, Sarosiek S, Quillen K, Shelton AC, Sanchorawala V. Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis. Bone Marrow Transplant. 2018 Mar; 53(3):371-373. PMID: 29269794.

    Read at: PubMed
  • Published on 9/1/2017

    Batalini F, Econimo L, Quillen K, Sloan JM, Sarosiek S, Brauneis D, Havasi A, Stern L, Dember LM, Sanchorawala V. High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease. Biol Blood Marrow Transplant. 2018 Jan; 24(1):127-132. PMID: 28865972.

    Read at: PubMed
  • Published on 7/11/2017

    Browning S, Quillen K, Sloan JM, Doros G, Sarosiek S, Sanchorawala V. Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation. Blood. 2017 09 14; 130(11):1383-1386. PMID: 28698204.

    Read at: PubMed
  • Published on 7/1/2017

    Sarosiek S, Rybin D, Kasotakis G. Inferior Vena Caval Filter Insertion in Trauma Patients-Reply. JAMA Surg. 2017 Jul 01; 152(7):707. PMID: 28384679.

    Read at: PubMed

View 9 more publications: View full profile at BUMC

View all profiles